J4I Stock Overview
Researches and develops polymer modification technologies and techniques in the United Kingdom, Slovenia, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Graft Polymer (UK) Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0005 |
| 52 Week High | UK£0.0075 |
| 52 Week Low | UK£0.0005 |
| Beta | 1.89 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -92.86% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| J4I | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.02% |
| 1Y | -92.9% | -2.0% | 8.2% |
Return vs Industry: J4I underperformed the German Chemicals industry which returned -1.6% over the past year.
Return vs Market: J4I underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| J4I volatility | |
|---|---|
| J4I Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine J4I's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 7 | Anthony Tennyson | www.graftpolymer.com |
Graft Polymer (UK) Plc, together with its subsidiaries, researches and develops polymer modification technologies and techniques in the United Kingdom, Slovenia, and Europe. The company offers GRAFTABOND, a line of graft/block copolymers for combining various polymers with fiberglass, carbon fiber, mineral, natural fillers, and mixed polymer waste; GRAFTALEN, a line of reactive solid super-concentrates for polyolefin rheology modification, e-modulus enhancers, PET/PBT chain extenders, and AOX masterbatch; and GRAFTAPOR, a line of porous polymer-carriers for use in liquid chemicals. It also provides GRAFTAMID, a line of high-temperature elastomers based on nanostructured polyolefin-polyamide alloys for high-tech hardening modifiers in polyamide compounds, as well as use as an independent compound in hot melt adhesives; and GRAFTAKIT, a reactive liquid or solid super-concentrates on polymeric porous media for carrying out reaction extrusion and modification of compounds.
Graft Polymer (UK) Plc Fundamentals Summary
| J4I fundamental statistics | |
|---|---|
| Market cap | €5.39m |
| Earnings (TTM) | -€2.96m |
| Revenue (TTM) | €417.55k |
12.9x
P/S Ratio-1.8x
P/E RatioIs J4I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| J4I income statement (TTM) | |
|---|---|
| Revenue | UK£347.00k |
| Cost of Revenue | UK£317.00k |
| Gross Profit | UK£30.00k |
| Other Expenses | UK£2.49m |
| Earnings | -UK£2.46m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0011 |
| Gross Margin | 8.65% |
| Net Profit Margin | -709.80% |
| Debt/Equity Ratio | 16.0% |
How did J4I perform over the long term?
See historical performance and comparison